Education
About Us
Working with TipRanks
Follow Us
VNGLF - ETF AI Analysis
Top Page
Vanguard FTSE Developed Europe UCITS ETF Accum EUR (VNGLF)
Rating:63Neutral
Price Target:―
Positive Factors
Strong Top Holdings
Several key holdings, such as ASML Holding NV and Nestlé SA, have delivered strong year-to-date performance, supporting the ETF’s overall returns.
Low Expense Ratio
The ETF has a very low expense ratio compared to industry averages, making it cost-effective for investors.
Broad Geographic Exposure
The fund invests across multiple European countries, reducing reliance on any single economy.
Negative Factors
Underperforming Holdings
Some top holdings, like SAP SE, have lagged in performance, which could drag on the fund’s overall returns.
Sector Concentration in Financials
Financials make up over 21% of the portfolio, increasing sensitivity to challenges in that sector.
Limited Non-European Exposure
The ETF has minimal exposure outside Europe, with only 4% allocated to U.S. companies, limiting diversification.
VNGLF vs. SPDR S&P 500 ETF (SPY)
AUM1.93B
RegionEurope
Expense Ratio0.10%
Beta0.64
IssuerVanguard
Inception DateJul 23, 2019
Dividend YieldN/A
Asset ClassEquity
Index TrackedFTSE Developed Europe Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume8,352
30 Day Avg. Volume13,283
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
67.95Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering497
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
VNGLF Summary
The Vanguard FTSE Developed Europe UCITS ETF (VNGLF) is an investment fund that tracks the FTSE Developed Europe Index, giving investors exposure to a wide range of companies in developed European countries like Germany, France, and the UK. It includes well-known companies such as Nestlé and AstraZeneca, and reinvests dividends to help grow your investment over time. This ETF is a great choice for those looking to diversify their portfolio with European stocks and benefit from the stability of established markets. However, new investors should note that its performance depends on the European economy, which can be affected by regional challenges like political or economic instability.
How much will it cost me?The Vanguard FTSE Developed Europe UCITS ETF (VNGLF) has an expense ratio of 0.1%, meaning you’ll pay $1 per year for every $1,000 invested. This is lower than average because the fund is passively managed, tracking the FTSE Developed Europe Index to keep costs down.
What would affect this ETF?Positive drivers for VNGLF include potential economic growth in developed European countries like Germany, France, and the UK, which could boost the performance of its top holdings in sectors such as financials, healthcare, and technology. However, negative factors such as rising interest rates or geopolitical tensions in Europe could impact market stability and weigh on the ETF's performance. Additionally, sector-specific challenges, like regulatory changes in healthcare or energy, could affect the fund's returns.
VNGLF Top 10 Holdings
The Vanguard FTSE Developed Europe UCITS ETF leans heavily on financials and industrials, with HSBC and Roche Holding AG providing a lift thanks to their steady growth and positive earnings momentum. AstraZeneca is also rising, driven by strong revenue and strategic progress. On the flip side, SAP and Siemens are lagging, weighed down by bearish sentiment and mixed technical signals. The fund’s broad exposure to developed European markets ensures diversification, but its concentration in healthcare and financials means performance hinges on these sectors staying in good health.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 3.18% | $183.45M | €365.67B | 43.06% | 76 Outperform | |
| SAP SE | 2.03% | $117.14M | €246.03B | -11.41% | 66 Neutral | |
| AstraZeneca | 1.87% | $108.01M | £209.51B | 27.27% | 78 Outperform | |
| HSBC Holdings | 1.85% | $106.85M | HK$1.91T | 43.00% | 79 Outperform | |
| Nestlé SA | 1.85% | $106.56M | CHF200.34B | 15.56% | 71 Outperform | |
| Novartis AG | 1.76% | $101.56M | CHF203.41B | 18.26% | 80 Outperform | |
| Roche Holding AG | 1.73% | $99.61M | CHF248.29B | 35.94% | 73 Outperform | |
| Shell (UK) | 1.68% | $96.73M | £160.14B | 12.25% | 74 Outperform | |
| Siemens | 1.59% | $91.54M | €180.29B | 20.82% | 74 Outperform | |
| LVMH Moet Hennessy Louis Vuitton | 1.37% | $79.27M | €314.71B | 3.87% | 78 Outperform |
VNGLF Technical Analysis
Positive
―
Price Trends
60.18
Positive
59.19
Positive
56.66
Positive
Market Momentum
0.26
Negative
59.05
Neutral
91.67
Negative
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For VNGLF, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 60.27, equal to the 50-day MA of 60.18, and equal to the 200-day MA of 56.66, indicating a bullish trend. The MACD of 0.26 indicates Negative momentum. The RSI at 59.05 is Neutral, neither overbought nor oversold. The STOCH value of 91.67 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for VNGLF.
VNGLF Peer Comparison
Comparison Results
Performance Comparison
VNGLF
Vanguard FTSE Developed Europe UCITS ETF Accum EUR
61.19
12.78
26.40%
EZU
iShares MSCI Eurozone ETF
―
―
―
BBEU
JPMorgan BetaBuilders Europe ETF
―
―
―
IEUR
iShares Core MSCI Europe ETF
―
―
―
FEZ
SPDR EURO STOXX 50 ETF
―
―
―
HEDJ
WisdomTree Europe Hedged Equity Fund
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents